SNGX · Soligenix Inc
United States · RS rating 38 · As of 2026-11-03
| Price | 0.36 USD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 38 / 53 / 53 / 10 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 8 / 55 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +57.1% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +78.4% |
| Market cap (USD) | $14.1M |